• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home StudyGraphics

#VisualAbstract: Early physical therapy effective in reducing disability for patients with lower back pain

byConstance Wu
October 15, 2020
in StudyGraphics
Reading Time: 3 mins read
#VisualAbstract: Early physical therapy effective in reducing disability for patients with lower back pain
Share on FacebookShare on Twitter

1. Early physical therapy (EPT) was more effective than usual care alone for reducing disability, back pain, and fear-avoidance beliefs at 4 weeks. Benefits in the former two extended with some attenuation to 1 year.

2. While health care use and missed work were similar between groups, patient-reported success was significantly higher in the EPT group at both the 4-week and 1-year time points.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Back pain is the costliest medical condition in the United States, with nearly 80% of the population experiencing symptoms at some point in their lives. Because many cases resolve spontaneously regardless of intervention, many providers elect to adopt a stepped-care approach in which referral to physical therapy is withheld until insufficient improvement from self-management is noted after some time. This study sought to determine whether physical therapy would be an effective first-line treatment for recent-onset (90 days or less) low back pain and sciatica, finding that patients who received early physical therapy (EPT) had significantly greater reductions in both Oswestry Disability Index scores and numeric back pain rating scale scores at 4 weeks compared to those who received usual care (UC). Further, between-group differences in favor of those who received EPT were detected in the two secondary outcomes of quality of life and self-reported health. Though the EPT group experienced sustained benefit over time, these observed differences diminished over 1 year due to substantial improvements that were eventually seen in the UC group. While these results support the more widespread utilization of physical therapy, they have somewhat limited generalizability because of considerable sample homogeneity and a failure to address risk stratification. Further research into specific patient populations may help identify subgroups that would reap the greatest benefit from EPT, thus allowing for greater precision in the targeting of therapy.

Click here to read the study in Annals of Internal Medicine

Relevant Reading: Implications of early and guideline adherent physical therapy for low back pain on utilization and costs

RELATED REPORTS

Physical therapy yields modest improvements in chronic low back pain

#VisualAbstract: An Individualised, Progressive Walking and Education Intervention is Effective for the Prevention of Low Back Pain Recurrence

The 2 Minute Medicine Podcast Episode 24

In-Depth [randomized controlled trial]: This study was conducted in two healthcare systems in Salt Lake City, Utah. 220 patients were enrolled from February 2015 to October 2018 and randomized in a 1:1 ratio using permuted blocks to receive either EPT or UC, which consisted of only advice and education. The two groups were similar with regard to most demographic and clinical characteristics at baseline, but the UC group contained 10% more women than the EPT group, and over 80% of both groups were White. At 4 weeks, the EPT group had a −17.0 (95% CI, −19.7 to −14.2) point change in Oswestry Disability Index score compared to only a −8.8 (−11.5 to −6.0) point change in the UC group (relative difference, −8.2; 95% CI, −12.1 to −4.3). By 1 year, this difference had lessened to −4.8 (95% CI, −8.9 to −0.7) points, which no longer fell within the minimum clinically important difference range of 6 to 8 points. The same trend was observed in a 10-point back pain rating scale, for which the relative difference in mean change from baseline at 4 weeks was −1.4 (95% CI, −2.0 to −0.9) points at 4 weeks but diminished to −1.0 (−1.6 to −0.4) points at 1 year. Again, while between-group differences in improvement in EQ-5D quality of life (relative difference, 0.07 points on a 1-point scale; 95% CI, 0.02 to 0.11) and self-reported health (relative difference, 8.5 points on a 100-point scale; 95% CI 3.8 to 13.3) were statistically significant at 4 weeks, the two groups had similar scores at 1 year. Patient satisfaction appeared to be higher in the EPT group, however, as a greater percentage of participants self-reported success at both 4 weeks (28.6% versus 12.3%) and 1 year (45.2% versus 27.6%).

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: lower back painphysical therapySciatica
Previous Post

Increased proportion of out of hospital cardiac arrests at start at COVID-19

Next Post

Pre-hospital administration of TXA for patients at risk of hemorrhage not associated with improved 30-day mortality

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

Physical therapy yields modest improvements in chronic low back pain

April 20, 2026
#VisualAbstract: An Individualised, Progressive Walking and Education Intervention is Effective for the Prevention of Low Back Pain Recurrence
StudyGraphics

#VisualAbstract: An Individualised, Progressive Walking and Education Intervention is Effective for the Prevention of Low Back Pain Recurrence

July 29, 2024
The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 24

September 26, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Shohei Sidelined? Blue Light Bust, Sciatica Struggles, and Concussion Effects

September 19, 2023
Next Post
No association found between length of storage for transfused red blood cells and patient mortality

Pre-hospital administration of TXA for patients at risk of hemorrhage not associated with improved 30-day mortality

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Fifteen year quality of life outcomes in men with localized prostate cancer: population based Australian prospective study

Quick Take: Factors associated with successful discontinuation of immune suppression after allogenic hematopoietic cell transplantation

Sorafenib maintenance therapy after allogenic stem cell transplantation reduces relapse rate in FLT3-ITD acute myeloid leukemia

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.